Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth
- 1 March 2007
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (4), 710-717
- https://doi.org/10.1016/j.ejca.2006.09.028
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Erythropoietin: Novel Approaches to Neuroprotection in Human Brain DiseaseMetabolic Brain Disease, 2004
- Erythropoietin and the hypoxic brainJournal of Experimental Biology, 2004
- Erythropoietin and the nervous systemBrain Research, 2004
- Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo modelsClinics in Perinatology, 2004
- Epoetin AlfaArchives of Internal Medicine, 2004
- New Insights Into Erythropoietin and Epoetin Alfa: Mechanisms of Action, Target Tissues, and Clinical ApplicationsThe Oncologist, 2003
- Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injuryEuropean Journal of Neuroscience, 2003
- The Pleiotropic Effects of Erythropoietin in the Central Nervous SystemJournal of Neuropathology and Experimental Neurology, 2003
- Pleiotropic Functions of Erythropoietin.Internal Medicine, 2003
- Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injuryThe FASEB Journal, 2001